AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Carl L.G. Hansen, PhD$1.2B
Market Cap • 23/04/20242012
(há 12 anos)
2020
(4 years ago)
NASDAQ
Listagem
Vancouver
Sede • BC495
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ABCLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.